Christie Matthews
A guide is only useful if it’s current. When a label, a price or a rule changes, the page should change with it.
What Christie Does Here
Christie researches and writes for GLP1Rating. She collects the facts behind our guides and articles and checks them against FDA labels, manufacturer pages, Medicare rules and other primary sources before anything is published.
She also follows what people say about GLP-1 drugs and providers on Reddit and social media, so our guides answer the questions people actually ask, and she keeps published pages current when a price, a label or a rule changes.
Beyond writing, she helps build and design the site and works on what GLP1Rating covers next.
She isn’t a doctor, nurse or pharmacist. Medical facts on the site come from FDA labels and other primary sources, and we link them so you can check.
What Christie Covers
Medication Facts
Christie checks what our guides say about GLP-1 drugs against FDA labels, FDA safety communications and published studies, and flags where providers overstate or understate the safety picture in their own materials.
Compounding Pharmacy Standards
Not all compounding pharmacies are equal. Christie records which pharmacies providers say they use, whether those pharmacies are FDA-registered, and what providers publish about shipping and cold chain.
Guides and Articles
Christie writes and updates our GLP-1 guides, including how the medications work, side effects and who is a good candidate. Side-effect information comes from FDA labels and published data, not from provider FAQs.
Christie is not a doctor, nurse or pharmacist, and nothing she writes is medical advice. Everything on our pages that touches on clinical facts is checked against published sources, which we link so you can read them yourself.
How Christie Works
Christie reads the actual studies, not the summaries. If a provider cites a clinical trial to support a safety claim, she checks whether the trial actually says that.
She compares what a provider says in its FAQs and marketing against the FDA label and published sources. Discrepancies go in the review.
The FDA’s position on compounded GLP-1s has changed multiple times. Christie monitors for new guidance and updates our safety sections when the regulatory picture shifts.
Christie follows GLP-1 discussions on Reddit and social media and notes when what people report doesn’t match how providers describe their service. We quote those reports as other people’s experiences, with links, not as medical advice.